BACE1 and Alzheimer disease: Our data demonstrated that AD patients possessed a lower level of miR-342-5p in sEVs in the peripheral blood, and sEV-derived miR-342-5p ameliorates Aβ formation in the recipient neurons by modulating BACE1 expression.